These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 15612650)

  • 1. Managing a Treatment-Resistant Schizophrenia Spectrum Disorder With a Hormonal Twist in a Female Patient: A Case Report of a Progestin-Only Pill.
    Scala M; Martínez Trapote P; Rodriguez-Jimenez R; Pecorino B; Serretti A
    J Clin Psychopharmacol; 2024 May-Jun 01; 44(3):323-326. PubMed ID: 38591793
    [No Abstract]   [Full Text] [Related]  

  • 2. 'Real world' comparison of first- and second-generation antipsychotics in regard to length of inpatient hospitalization and number of re-hospitalizations.
    Advokat C; Hill BD; Comaty JE
    Psychiatr Q; 2008 Mar; 79(1):55-64. PubMed ID: 18060498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [How to withdraw from multi-high-dose drug therapy for schizophrenia].
    Ishigooka J
    Seishin Shinkeigaku Zasshi; 2006; 108(6):597-8. PubMed ID: 16910536
    [No Abstract]   [Full Text] [Related]  

  • 4. [For: is monotherapy the gold standard of psychopharmacology?].
    Fehr C
    Psychiatr Prax; 2006 Jul; 33(5):207-8. PubMed ID: 16802258
    [No Abstract]   [Full Text] [Related]  

  • 5. Combination antipsychotic therapy for the treatment of schizophrenia.
    Tapp A; Kennedy A; Kilzieh N; Rosengren K; Wood A
    Essent Psychopharmacol; 2004; 6(1):1-11. PubMed ID: 15612650
    [No Abstract]   [Full Text] [Related]  

  • 6. [Acute phase drug therapy and drug switching in the treatment of patients with schizophrenia].
    Fujii Y
    Seishin Shinkeigaku Zasshi; 2001; 103(12):1030-5. PubMed ID: 11925840
    [No Abstract]   [Full Text] [Related]  

  • 7. [Simplification and optimization in drug therapy for patients with schizophrenia--knowledge and techniques in drug switching].
    Takeda T
    Seishin Shinkeigaku Zasshi; 2006; 108(6):624-30. PubMed ID: 16910541
    [No Abstract]   [Full Text] [Related]  

  • 8. [Trends in multi-high-dose drug therapy for schizophrenia in Japan].
    Miyamoto M
    Seishin Shinkeigaku Zasshi; 2006; 108(6):599-607. PubMed ID: 16910537
    [No Abstract]   [Full Text] [Related]  

  • 9. [Necessity of novel single-antipsychotic-agent therapies for acute phase of schizophrenia].
    Tsutsumi Y
    Seishin Shinkeigaku Zasshi; 2006; 108(6):619-23. PubMed ID: 16910540
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.